Construction of SH-EP1-α4β2-hAPP695 cell line and effects of nicotinic agonists on β-amyloid in the cells

Cellular and Molecular Neurobiology

Volumn 28, Issue 1, 2008, Pages 103-112

  Nie, Huizhen ^a   Li, Zuoqing ^a   Lukas, Ronald J ^b   Shen, Yinghua ^a   Song, Li ^a   Wang, Xin ^a   Yin, Ming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

4 2 subtype; Amyloid; Alzheimer's disease; Epibatidine; Nicotine; Nicotinic acetylcholine receptors

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; EPIBATIDINE; LIPOSOME; MESSENGER RNA; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMYLOID BETA-PROTEIN PRECURSOR; CELL CULTURE TECHNIQUES; CELL LINE; CLONE CELLS; ELECTROPHORESIS, AGAR GEL; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE POTENTIALS; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PEPTIDE FRAGMENTS; PLASMIDS; RECEPTORS, NICOTINIC; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER;

EID: 39149084653     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-007-9218-1     Document Type: Article

References (33)

1. Champtiaux N, Han ZY, Bessis A, Rossi FM, Zoli M, Marubio L et al. (2002) Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice. J Neurosci 22:1208-1217
2. Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P (1995) Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16:285-298
3. Dovey HF, John V, Anderson JP, Chen LZ, de Saint Andrieu P et al. (2001) Functional gammasecretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem 76:173-181
4. Dunbar GC, Inglis F, Kuchibhatla R, Sharma T, Tomlinson M, Wamsley J (2007) Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI). J Psychopharmacol 21:171-178
5. Ferreira M, Ebert SN, Perry DC, Yasuda RP, Baker CM, Davila-Garcia MI et al. (2001) Evidence of a functional alpha7-neuronal nicotinic receptor subtype located on motoneurons of the dorsal motor nucleus of the vagus. J Pharmacol Exp Ther 296:260-269
6. Fukumoto H, Cheung BS, Hyman BT, Irizarry MC (2002) Beta-secretase protein and activity are increased in the neocortex inAlzheimer disease. Arch Neurol 59:381-1389
7. Gotti C, Clementi F (2004) Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74:363-396
8. Gotti C, Riganti L, Vailati S, Clementi F (2006) Brain neuronal nicotinic receptors as new targets for drug discovery. Curr Pharm Des 12:407-428
9. Hellström-Lindahl E, Court J, Keverne J, Svedberg M, Lee M, Marutle A, Thomas A, Perry E, Bednar I, Nordberg A (2004) Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice. Eur J Neurosci 19:2703-2710
10. Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G (2002) Increased expression of the amyloid precursor beta-secretase in Alzheimer's Disease. Ann Neurol 51:783-786
11. Karlin A (2002) Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci 3:102-114
12. Lena C, de Kerchove D'Exaerde A, Cordero-Erausquin M, Le Novere N, del Mar Arroyo-Jimenez M, Changeux JP (1999) Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons. Proc Natl Acad Sci USA 96:2126-12131
13. Lippiello P, Letchworth SR, Gatto GJ, Traina VM, Bencherif M (2006) Ispronicline a novel α4β2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties. J Mol Neurosci 30:19-20
14. Liu Q, Zhang J, Zhu H, Qin C, Qin C, Zhao Bl (2007) Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model. FASEB J 21:61-73
15. Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430:631-639
16. Moehlmann T, Winkler E, Xia X, Edbauer D, Murrell J, Capell A, Kaether C, Zheng H, Ghetti B, Haass C (2002) Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci USA 99:8025-8030
17. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer_s disease mutations: potential factors in amyloid plaque formation. J Neurosci 26:10129-10140
18. O'Brien JT, Colloby SJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, McKeith IG, Williams ED (2007) α4β2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography. J Neurol Neurosurg Psychiatry 78:356-362
19. Oddo S, LaFerla FM (2006) The role of nicotinic acetylcholine receptors in Alzheimer's disease. J Physiol (Paris) 99:172-179
20. Pallavicini M, Moroni B, Bolchi C, Cilia A, Clementi F, Fumagalli L, Gotti C, Meneghetti F, Riganti L, Vistolia G, Valotia E (2006) Synthesis and a4b2 nicotinic affinity of unichiral 5-(2-pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes. Bioorg Med Chem Lett 16:5610-5615
21. Paterson D, Nordberg A (2000) Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61:75-111
22. Perez RG, Soriano S, Hayes JD, Ostaszewski B, Xia W, Selkoe DJ, Chen X, Stokin GB, Koo EH (1999) Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J Biol Chem 274:18851-18856
23. Perry DC, Xiao Y, Nguyen HN, Musachio JL, Davila-Garcia MI, Kellar KJ (2002) Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography. J Neurochem 82:468-481
24. Qi XL, Nordberg A, Xiu J, Guan ZZ (2007) The consequences of reducing expression of the a7 nicotinic receptor by RNA interference and of stimulating its activity with an a7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease. Neurochem Int. www.elsevier.com/locate/neuint
25. Sadowski M, Pankiewicz J, Scholtzova H, Ji Y, Quartermain D, Jensen CH, Duff K, Nixon RA, Gruen RJ, Wisniewski T (2004) Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice. J Neuropathol Exp Neurol 63: 418- 428
26. Selkoe DJ (1994) Amyloid beta-protein Precursor: new clues to the genesis of Alzheimer's disease. Curr Opin Neurobiol 4:708-716
27. Sommer B (2002) Alzheimer's disease and the amyloid cascade hypothesis: ten years on. Curr Opin Pharmacol 2:87-92
28. Tribollet E, Bertrand D, Marguerat A, Raggenbass M (2004) Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience 124:405-420
29. Vickers JC, Dickson TC, Adlard PA, Saunders HL, King CE, McCormack G (2000) The cause of neuronal degeneration in Alzheimer's disease. Prog Neurobiol 60:139-165
30. Weihl CC, Ghadge GD, Kennedy SG, Hay N, Miller RJ, Roos RP (1999) Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J Neurosci 19:5360-5369
31. Wevers A, Schroder H (1999) Nicotinic acetylcholine receptors in Alzheimer's disease. J Alzheimers Dis 1:207-219
32. Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, Beach T, Sue L, Wong P, Price D (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9:3-4
33. Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, Gotti C (2002) Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci 22:8785-8789